These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12972706)

  • 21. [Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide].
    Iguchi T; Yokoyama K; Miyamoto K; Aisa Y; Shimizu T; Mori T; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Jan; 45(1):75-7. PubMed ID: 14999939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3).
    Zhang T; Westervelt P; Hess JL
    Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-
    Lu J; Huang X; Bao L; Jiang H; Zhu H; Jiang B
    Oncol Lett; 2014 Jan; 7(1):177-182. PubMed ID: 24348844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Mousavi A; Iravani M; Rostami S; Ghaffari H; Hosseini R; Jalili M
    Arch Iran Med; 2011 May; 14(3):167-9. PubMed ID: 21529103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute promyelocytic leukaemia.
    Fenaux P; Chomienne C; Degos L
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
    Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modern approaches to treating acute promyelocytic leukemia.
    Sanz MA; Lo-Coco F
    J Clin Oncol; 2011 Feb; 29(5):495-503. PubMed ID: 21220600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia.
    Hashmi H; Nishihori T
    Clin Transplant; 2020 Sep; 34(9):e14009. PubMed ID: 32526047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.
    Ferrara F; Finizio O; Izzo T; Riccardi C; Criscuolo C; Carbone A; Borlenghi E; Rossi G
    Anticancer Res; 2010 Sep; 30(9):3845-9. PubMed ID: 20944181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
    Lachaine J; Mathurin K; Barakat S; Couban S
    Eur J Haematol; 2015 Sep; 95(3):218-29. PubMed ID: 25354894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.
    Ohno R; Asou N; Ohnishi K
    Leukemia; 2003 Aug; 17(8):1454-63. PubMed ID: 12886231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
    Lou Y; Suo S; Tong Y; Tong H; Qian W; Meng H; Mai W; Huang J; Yu W; Jin J
    Ann Hematol; 2014 Jun; 93(6):941-8. PubMed ID: 24408159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curative therapeutic approaches to APL.
    Tallmann MS
    Ann Hematol; 2004; 83 Suppl 1():S81-2. PubMed ID: 15124685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic cell transplantation in acute promyelocytic leukemia: a comprehensive review.
    Kharfan-Dabaja MA; Abou Mourad YR; Fernandez HF; Pasquini MC; Santos ES
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):997-1004. PubMed ID: 17697961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.
    Soignet SL; Maslak P; Wang ZG; Jhanwar S; Calleja E; Dardashti LJ; Corso D; DeBlasio A; Gabrilove J; Scheinberg DA; Pandolfi PP; Warrell RP
    N Engl J Med; 1998 Nov; 339(19):1341-8. PubMed ID: 9801394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.